Table 2. Formulation of the ASDs with the Weight Ratio of Each Component.
| polymer-drug system | polymer (% w/w) | drug(s) (% w/w) | drug ratioa |
|---|---|---|---|
| PVP-ATV | 90 | 10 | n/a |
| PVP-RTV | 90 | 10 | n/a |
| PVP-ATV-RTV | 90 | 10 | 25:75 |
| PVP-ATV-RTV | 90 | 10 | 50:50 |
| PVP-ATV-RTV | 90 | 10 | 75:25 |
| HPMCAS-FDN | 80 | 20 | n/a |
| HPMCAS-IPM | 80 | 20 | n/a |
| HPMCAS-FDN-IPM | 80 | 20 | 25:75 |
| HPMCAS-FDN-IPM | 80 | 20 | 50:50 |
| HPMCAS-FDN-IPM | 80 | 20 | 75:25 |
| HPMCAS-FDN-IPM | 80 | 20 | 90:10 |
Only applicable for formulations containing two drugs. n/a: not applicable.